methods for treating a hyperproliferative disorder, for determining compounds, for monitoring, for optimizing therapeutic efficacy and for identifying a biomarker; pharmaceutical formulation; use of a therapeutic combination and gdc-0032, article of manufacture, product and invention
Methods and compositions are provided for treating hyperproliferative disorders in patients with a PI3K inhibitor, GDC-0032 as a single agent or in combination with chemotherapeutic agents.